Search results
Results from the WOW.Com Content Network
At the same time, Summa might attract new young and middle-aged health care workers from across the country who will see the Akron-based hospital system as a place they want to work.
Dr. Sterling Shriber, a resident at Summa, has launched a change.org petition to maintain Summa’s nonprofit status. So far, it has more than 300 signatures. So far, it has more than 300 signatures.
Summa’s conversion to for-profit status also would result in the creation of a new foundation dedicated to societal issues that impact health, as well as an estimated $14.6 million annually in ...
A Christian chapel at Summa St. Thomas Hospital. It was used by patients, their families, and hospital staff for prayer and worship. On August 16, 1935, Sister Ignatia Gavin, a Catholic sister in charge of admissions at St. Thomas Hospital, with the help of Dr. Bob Smith, one of the founders of Alcoholics Anonymous, admitted the first alcoholic patient under the diagnosis of acute gastritis.
More than 1,300 licensed, inpatient beds are represented on the Summa Health Akron Campus, Summa Health St. Thomas Campus, Summa Health Rehab Hospital, and Summa Health Barberton Campus. In January 2024, Venture Capital firm General Catalyst announced it has agreed to purchase Summa Health and reestablish it as a for-profit corporation. [11]
Summa Akron City Hospital is a Level I trauma center with 100 emergency/trauma patient care spaces, and is a nationally ranked 750-bed non-profit, teaching hospital located in Akron, Ohio. Summa Akron City Hospital is also a Certified Chest Pain Center and a Comprehensive Stroke Center, and its obstetrics care is nationally recognized for ...
Blunt said that roughly 9,000 people would be affected if Summa leaves Anthem's network. Contact reporter Derek Kreider at DKreider@Gannett.com or 330-541-9413 .
He is best known for his work in caring and developing treatments for children with rare genetic diseases. Summar is the Chief Executive Officer of Uncommon Cures. [5] In 2022, he stepped down as Director of the Rare Disease Institute and as Chief of Genetics and Metabolism at Children's National Hospital in Washington D.C..